| Editor's Note: Fierce PM will not publish on Monday in observance of Labor Day in the U.S. We'll be back in your inbox on Tuesday, September 5. |
|
Generative AI has the potential to accelerate innovations across the value chain, from R&D to commercialization. Watch this webinar series to learn why nine out of the top 10 biopharma organizations use AWS for machine learning and analytics. Watch now.
|
|
Today’s Big NewsSep 1, 2023 |
|
Government Biotechnology Innovation Summit Convenes September 27-28 in National Harbor, MD. Hear from government leaders at the forefront on how biotechnology is transforming the economic, agricultural, healthcare and security landscape of the U.S. Learn more.
|
|
| By Fraiser Kansteiner Friday, the U.S. Federal Trade Commission (FTC) said it reached a proposed consent order with Amgen to address “the potential competitive harm” that could result from the merger deal. Now, Amgen is free to go forward with its $28 billion buyout. |
|
|
|
By James Waldron Sana Biotechnology isn't revealing how many employees have been affected by its latest round of layoffs, only confirming that the CAR-T-focused company has sought further “operational efficiencies.” |
By Andrea Park In a flurry of Aug. 31 notices from the FDA, the number of Class I recalls plaguing Getinge’s Cardiosave intra-aortic balloon pumps this year has doubled. |
By Nick Paul Taylor NexImmune is handing out pink slips again. Running close to the end of its cash runway, the immunotherapy biotech is halving its head count to support investment in its nanoparticle platform. |
|
Wednesday, September 6, 2023 | 2:00 PM ET / 11:00 AM PT Attendees will learn about the latest tools for interacting with medical images, how to guide readers through labeling workflows, and streamlining adjudication and data standardization. Discussions will include real-world use cases of how pharma companies are enhancing AI development by optimizing reader workflows. Register now.
|
|
By Angus Liu After a groundbreaking approval for Tecentriq, Roche has another positive early-stage lung cancer trial to celebrate. This time, the honor belongs to a targeted therapy in Alecensa. |
By Max Bayer Japanese pharma Otsuka is acquiring Mindset Pharma for $59 million, adding a suite of preclinical psychedelics. The larger company is looking to build on its portfolio of Lundbeck-partnered antipsychotics that each raked in hundreds of millions of dollars last quarter. |
By Conor Hale The system combines single-use hardware with real-time imaging software and allows the surgeon to collect biopsy samples from suspicious nodules in the periphery of the lungs via a video-game-like controller. |
By Angus Liu GSK is laying out more than 250 million euros ($273 million) to bolster vaccine manufacturing with a new facility in Wavre, Belgium. The unit will handle freeze-dried vaccines, including Shingrix and Arexvy. |
By Andy Miller and Sam Whitehead, KFF Health News Artificial intelligence is working its way into more parts of American life. As AI spreads within the health care landscape, it brings familiar concerns of bias and accuracy and whether government regulation can keep up with rapidly advancing technology. |
By Nick Paul Taylor Bavarian Nordic’s vision of ending the COVID-19 vaccine adaptation cycle is over. The Danish drugmaker found its phase 3 trial data support the need for variant-specific vaccines and, because its shot cannot be adapted quickly, has accepted the candidate “no longer represents a commercial opportunity.” |
By Kevin Dunleavy Bayer plans three new trials to assess its potential blockbuster medicine Kerendia in heart failure. The drug was first approved 2 years ago in CKD associated with diabetes. |
Fierce podcastsDon’t miss an episode |
| | This week on "The Top Line," we discuss the trends seen at Cannes Lions, the top compensated CEOs in the industry, and the cancer drug shortage |
|
|---|
|
|
| WhitepaperLearn how a GPCR-focused library with a cell-based biopanning strategy led to the discovery of 13 high-affinity and selective anti-GLP-1R antibodies with highly developable therapeutic properties. Sponsored by: Twist Bioscience |
| WhitepaperLearn more about how you can improve the productivity of your research and manufacturing operations and accelerate the journey from laboratory to saving lives. Sponsored by: JLL |
| Whitepaper15 biotech executives from the Cambridge area discuss the current biotech landscape, as well as challenges, opportunities, and best practices for emerging biotech companies seeking success in the UK and beyond. Sponsored by: Blue Matter, strategic consultants in the life sciences |
| WhitepaperLearn how process liquids and buffers impact your total cost of ownership (TCO) and how outsourcing can revolutionize your approach, ensuring quality standards and improving productivity. Sponsored by: Thermo Fisher Scientific Process Liquid Preparation Services |
| WebinarDownload this webinar to learn how to avoid pitfalls when characterizing CAR-T cells in your development workflow, how to save time by using one antibody to examine your entire panel of CARs, and more. Sponsored by: Cell Signaling Technology |
| |
|
